FREDUN PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]
FREDUN PHARMACEUTICALS Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹103 Cr | ₹107 Cr | ₹79 Cr | ₹118 Cr | ₹87 Cr | ₹82 Cr | ₹62 Cr | ₹80 Cr |
Expenses | ₹89 Cr | ₹93 Cr | ₹68 Cr | ₹107 Cr | ₹76 Cr | ₹72 Cr | ₹54 Cr | ₹68 Cr |
Operating Income | ₹13 Cr | ₹14 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹8 Cr | ₹12 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹7 Cr | ₹8 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹4 Cr | ₹8 Cr |
Profit After Tax | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹4 Cr |
EPS | ₹11.29 | ₹9.05 | ₹8.79 | ₹10.77 | ₹8.98 | ₹8.41 | ₹5.24 | ₹8.59 |
Industry Peers & Returns | 1W | 1M | 1Y |
FREDUN PHARMACEUTICALS | 5.6% | 5.9% | -18.1% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
CIPLA | -1.8% | 1% | 0.5% |
TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
LUPIN | -2.7% | 1% | 30.1% |
FREDUN PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -4.34 % |
Y-o-Y | 18.03 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹103 Cr | -4.34 | |
Sep2024 | ₹107 Cr | 36.22 | |
Jun2024 | ₹79 Cr | -33.23 | |
Mar2024 | ₹118 Cr | 35.66 | |
Dec2023 | ₹87 Cr | 6.13 | |
Sep2023 | ₹82 Cr | 32.14 | |
Jun2023 | ₹62 Cr | -22.25 | |
Mar2023 | ₹80 Cr | - |
FREDUN PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -5.18 % |
Y-o-Y | 25.81 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹13 Cr | -5.18 | |
Sep2024 | ₹14 Cr | 33.14 | |
Jun2024 | ₹10 Cr | -6.16 | |
Mar2024 | ₹11 Cr | 6.20 | |
Dec2023 | ₹11 Cr | 9.44 | |
Sep2023 | ₹10 Cr | 26.30 | |
Jun2023 | ₹8 Cr | -37.95 | |
Mar2023 | ₹12 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.92 % |
Y-o-Y | 6.53 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 12.88% | -0.92 | |
Sep2024 | 13% | -2.26 | |
Jun2024 | 13.3% | 40.59 | |
Mar2024 | 9.46% | -21.75 | |
Dec2023 | 12.09% | 3.16 | |
Sep2023 | 11.72% | -4.40 | |
Jun2023 | 12.26% | -20.18 | |
Mar2023 | 15.36% | - |
FREDUN PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 24.78 % |
Y-o-Y | 26.34 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹5 Cr | 24.78 | |
Sep2024 | ₹4 Cr | 3.46 | |
Jun2024 | ₹4 Cr | -18.41 | |
Mar2024 | ₹5 Cr | 19.95 | |
Dec2023 | ₹4 Cr | 7.21 | |
Sep2023 | ₹4 Cr | 63.91 | |
Jun2023 | ₹2 Cr | -38.28 | |
Mar2023 | ₹4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 30.40 % |
Y-o-Y | 7.01 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 5.19 % | 30.40 | |
Sep2024 | 3.98 % | -24.05 | |
Jun2024 | 5.24 % | 22.14 | |
Mar2024 | 4.29 % | -11.55 | |
Dec2023 | 4.85 % | 1.04 | |
Sep2023 | 4.8 % | 24.03 | |
Jun2023 | 3.87 % | -20.70 | |
Mar2023 | 4.88 % | - |
FREDUN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 24.75 % |
Y-o-Y | 25.72 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹11.29 | 24.75 | |
Sep2024 | ₹9.05 | 2.96 | |
Jun2024 | ₹8.79 | -18.38 | |
Mar2024 | ₹10.77 | 19.93 | |
Dec2023 | ₹8.98 | 6.78 | |
Sep2023 | ₹8.41 | 60.50 | |
Jun2023 | ₹5.24 | -39.00 | |
Mar2023 | ₹8.59 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD